Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy Sandokan

Start price
€32.44
07.12.23 / 50%
Target price
-
07.12.24
Performance (%)
-12.25%
Price
€28.35
16:35
Summary
This prediction is currently active. The price of Bayer AG has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.25%. Dividends of €0.12 are taken into consideration when calculating the performance. This prediction currently runs until 07.12.24. The prediction end date can be changed by Sandokan at any time. Sandokan has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m
Bayer AG 1.054% 1.054%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by Sandokan for this prediction

In the thread Bayer AG diskutieren

Sandokan hat das Wertpapier Bayer AG in seinem Wikifolio Wikifolio WF00RB6666 von Sandokan gekauft.

Stopped prediction by Sandokan for Bayer AG

buy
Bayer AG

Start price
Target price
Perf. (%)
€99.19
03.03.16
€107.00
19.04.16
8.48%
19.04.16